Abstract
© 2015, UBM Medica Healthcare Publications. All rights reserved. The treatment of patients with follicular lymphoma is undergoing a substantial shift due to rapid development of highly effective agents targeting lymphoma-specific biologic processes and the tumor microenvironment.
Original language | English |
---|---|
Pages (from-to) | 769-772 |
Journal | ONCOLOGY (United States) |
Volume | 29 |
Issue number | 10 |
Publication status | Published - 2015 |